Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,229 public trials 1,177 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY

NCT05735327

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Dolnoslskie Centrum Onkologii, Pulmonologii i Hematologii Wroclaw, Dolnoslskie, Poland
  • Szpital Kliniczny im. Heliodora Swiecickiego UM wPoznaniu. Poznan, Greater Poland Voivodeship, Poland
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Centrum Onkologii im.Prof. F. Lukaszczyka w Bydgoszczy Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
View Trial Details
Active, Not Recruiting

A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

NCT05872763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • Beijing Chest Hospital Beijing, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Active, Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

NCT03540420

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Aalborg Universitetshospital Aalborg, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • National Cancer Institute Vilnius, Lithuania
View all 41 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

NCT03937154

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Saint Bernards Medical Center Jonesboro, Arkansas, United States
  • Los Angeles Cancer Network Anaheim, California, United States
  • University of California Irvine Orange, California, United States
  • Colorado West Healthcare System dba Grand Valley Oncology Grand Junction, Colorado, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

NCT05183932

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Carle Cancer Institute Urbana, Illinois, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering New York, United States
View Trial Details
Active, Not Recruiting

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

NCT03410043

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • University of Colorado Denver, Colorado, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions